insights_auto
Why is TNXP down 2.66%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
US$2.75
arrow_downward
-2.66%(-0.075) 1D
ኖቬም 19, 12:02:54 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
US$2.83
High
US$2.84
Low
US$2.72
Mkt. cap
53.34 ሚ
Avg. vol.
1.11 ሚ
Volume
243.33 ሺ
52-wk high
US$20.56
52-wk low
US$2.72
EPS
-US$12.23
Beta
1.90
Shares outstanding
19.43 ሚ
No. of employees
142
Open
US$2.83
High
US$2.84
Low
US$2.72
Mkt. cap
53.34 ሚ
Avg. vol.
1.11 ሚ
Volume
243.33 ሺ
52-wk high
US$20.56
52-wk low
US$2.72
EPS
-US$12.23
Beta
1.90
Shares outstanding
19.43 ሚ
No. of employees
142
News stories
From web sources and news partners
Yahoo Finance
·
ከ3 ቀናት በፊት
TNXP: Tonmya® Launch Continues to Build Momentum; 37% QoQ Growth in Revenue
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websitetonixpharma.com